Acceptance and Commitment Therapy for Primary Headache Sufferers: A Randomized Controlled Trial of Efficacy

Area of Science:

• Psychology
• Behavioral Medicine
• Neurology

Background:

• Traditional headache management often relies on trigger avoidance, which can lead to negative consequences like reduced quality of life.
• Acceptance and Commitment Therapy (ACT) is an evidence-based approach for chronic pain, but its efficacy for headaches requires further investigation.
• Existing studies on ACT for headaches have methodological limitations.

Purpose of the Study:

• To evaluate the effectiveness of a headache-specific Acceptance and Commitment Therapy (ACT) group intervention compared to a wait-list control.
• To assess the impact of ACT on disability, distress, medical utilization, functioning, and quality of life in individuals with primary headaches.

Main Methods:

• A randomized clinical trial involving 94 individuals diagnosed with primary headaches (87.35% migraine).
• Participants were randomized into an ACT group or a wait-list control group.
• Assessments were conducted pre-treatment, post-treatment, and at 3, 6, and 12-month follow-ups for the ACT group.

Main Results:

• The ACT group demonstrated substantial improvements in disability, quality of life, functional status, and depression compared to the control group.
• These improvements were maintained at 3-, 6-, and 12-month follow-ups.
• At 3-month follow-up, 63% of the ACT group showed improvement in headache-related disability and 65% in quality of life.

Conclusions:

• Acceptance and Commitment Therapy (ACT) is an effective intervention for primary headaches, leading to statistically and clinically significant improvements.
• ACT offers a promising alternative to traditional trigger avoidance, enhancing functioning and quality of life for headache sufferers.
• The study provides robust evidence for the long-term utility and efficacy of ACT in managing localized pain conditions like primary headaches.